Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albertus Beishuizen

Showing results (141-150 of 162) with videos related to

Pageof 17
Sort By:
Critical Care (London, England)|February 16, 2021
Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational studyAlice Blet, Benjamin Deniau, Karine Santos, et al.
Science Translational Medicine|July 31, 2024
Super-relaxed myosins contribute to respiratory muscle hibernation in mechanically ventilated patientsMarloes van den Berg, Zhonghua Shi, Wout J Claassen, et al.
JAMA|February 22, 2018
Effect of Haloperidol on Survival Among Critically Ill Adults With a High Risk of Delirium: The REDUCE Randomized Clinical TrialMark van den Boogaard, Arjen J C Slooter, Roger J M Brüggemann, et al.
American Heart Journal|October 24, 2024
A randomized embedded multifactorial adaptive platform for extra corporeal membrane oxygenation (REMAP ECMO) - design and rationale of the left ventricular unloading trial domainMyrthe P J van Steenwijk, Joost van Rosmalen, Carlos V Elzo Kraemer, et al.
Scientific Reports|March 26, 2025
Assessing differential application of thromboprophylaxis regimes related to risk of pulmonary embolism and mortality in COVID-19 patients through instrumental variable analysisLinda Nab, Chantal Visser, Bas C T van Bussel, et al.
The Lancet. Infectious Diseases|March 8, 2016
Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trialEvelien de Jong, Jos A van Oers, Albertus Beishuizen, et al.
Age and Ageing|May 16, 2021
Duration of antibiotic treatment using procalcitonin-guided treatment algorithms in older patients: a patient-level meta-analysis from randomized controlled trialsEva Heilmann, Claudia Gregoriano, Djillali Annane, et al.
The New England Journal of Medicine|February 23, 2022
Treating Rhythmic and Periodic EEG Patterns in Comatose Survivors of Cardiac ArrestBarry J Ruijter, Hanneke M Keijzer, Marleen C Tjepkema-Cloostermans, et al.
The Cochrane Database of Systematic Reviews|October 13, 2017
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infectionsPhilipp Schuetz, Yannick Wirz, Ramon Sager, et al.
The European Respiratory Journal|October 13, 2022
A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR)Jatin Patel, Damon Bass, Albertus Beishuizen, et al.
Pageof 17

Showing results (141-150 of 162) with videos related to

Sort By:
Pageof 17
Critical Care (London, England)|February 16, 2021
Monitoring circulating dipeptidyl peptidase 3 (DPP3) predicts improvement of organ failure and survival in sepsis: a prospective observational multinational studyAlice Blet, Benjamin Deniau, Karine Santos, et al.
Science Translational Medicine|July 31, 2024
Super-relaxed myosins contribute to respiratory muscle hibernation in mechanically ventilated patientsMarloes van den Berg, Zhonghua Shi, Wout J Claassen, et al.
JAMA|February 22, 2018
Effect of Haloperidol on Survival Among Critically Ill Adults With a High Risk of Delirium: The REDUCE Randomized Clinical TrialMark van den Boogaard, Arjen J C Slooter, Roger J M Brüggemann, et al.
American Heart Journal|October 24, 2024
A randomized embedded multifactorial adaptive platform for extra corporeal membrane oxygenation (REMAP ECMO) - design and rationale of the left ventricular unloading trial domainMyrthe P J van Steenwijk, Joost van Rosmalen, Carlos V Elzo Kraemer, et al.
Scientific Reports|March 26, 2025
Assessing differential application of thromboprophylaxis regimes related to risk of pulmonary embolism and mortality in COVID-19 patients through instrumental variable analysisLinda Nab, Chantal Visser, Bas C T van Bussel, et al.
The Lancet. Infectious Diseases|March 8, 2016
Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trialEvelien de Jong, Jos A van Oers, Albertus Beishuizen, et al.
Age and Ageing|May 16, 2021
Duration of antibiotic treatment using procalcitonin-guided treatment algorithms in older patients: a patient-level meta-analysis from randomized controlled trialsEva Heilmann, Claudia Gregoriano, Djillali Annane, et al.
The New England Journal of Medicine|February 23, 2022
Treating Rhythmic and Periodic EEG Patterns in Comatose Survivors of Cardiac ArrestBarry J Ruijter, Hanneke M Keijzer, Marleen C Tjepkema-Cloostermans, et al.
The Cochrane Database of Systematic Reviews|October 13, 2017
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infectionsPhilipp Schuetz, Yannick Wirz, Ramon Sager, et al.
The European Respiratory Journal|October 13, 2022
A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR)Jatin Patel, Damon Bass, Albertus Beishuizen, et al.
Pageof 17